In this issue:
- Tumour-infiltrating lymphocytes in triple-negative breast cancer
- Enobosarm in AR+, ER+, and HER2- advanced breast cancer
- Five-year efficacy outcomes in monarchE
- Long-term patient-reported outcomes from monarchE
- Trade-offs between OS and adverse events
- Aspirin as adjuvant therapy for breast cancer
- Omitting axillary dissection in breast cancer with sentinel-node metastases
- Nurse-led individualised follow-up after early breast cancer
- Ethnic inequities in breast conserving surgery and radiation therapy
- Omission of adjuvant radiotherapy in low-risk male breast cancer
Please login below to download this issue (PDF)